A null-pointer-dereference in the signature verification module in AVG/Avast Antivirus signature <24092400 released on 24/Sep/2024 on MacOS may allow a malformed xar file to crash the application during processing.
This vulnerability carries a MEDIUM severity rating with a CVSS v3.1 score of 5.1, requiring local system access to exploit but requires specific conditions to be met without requiring user interaction and does not require pre-existing privileges . The vulnerability impacts and availability (service disruption) for affected systems. Impacting 2 products from avast, from avg organizations running these solutions should prioritize assessment and patching.
Reported in 2024, this vulnerability emerged during an era marked by increased sophistication in supply chain attacks, cloud infrastructure vulnerabilities, and software-as-a-service (SaaS) security challenges. Security practices during this period emphasized zero-trust architectures, container security, and API protection.
2024-10-04T13:15:12.980
2024-11-08T20:54:30.980
Analyzed
CVSSv3.1: 5.1 (MEDIUM)
| Type | Vendor | Product | Version/Range | Vulnerable? |
|---|---|---|---|---|
| Application | avast | antivirus | < 24092400 | Yes |
| Application | avg | antivirus | < 24092400 | Yes |
SecUtils normalizes and enriches National Vulnerability Database (NVD) records by standardizing vendor and product identifiers, aggregating vulnerability metadata from both NVD and MITRE sources, and providing structured context for security teams. For avast's affected products, we extract Common Platform Enumeration (CPE) data, Common Weakness Enumeration (CWE) classifications, CVSS severity metrics, and reference data to enable rapid vulnerability prioritization and asset correlation. This record contains no exploit code, proof-of-concept instructions, or attack methodologies—only defensive intelligence necessary for patch management, risk assessment, and security operations.